Company profile
Solvotrin Therapeutics company profile
Solvotrin Therapeutics Limited is a privately held pharmaceutical company focused on cardiovascular applications. Solvotrin’s business model is based on the development of new drugs that combine its unique patented prodrug platform with well established compounds in large markets. Its approach of chemically creating new chemical entities from existing compounds for synergistic benefits creates efficacy and safety advantages with significantly reduced development timeline and development risk. Solvotrin’s lead compound, ST0702 is a nicotinic acid prodrug, with significant efficacy and tolerability advantages over similar products for 54 dyslipidaemia. ST0701 is a bioactivated form of aspirin, which addresses the well documented gastrointestinal toxicity..... For more information, log in to dureach.com to view the full company profile.
Business identity
- Website
- http://www.solvotrin.com/
- Contact email
- [email protected]
- Phone number
- +353 (021) 4510220
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00011-00050 employees
- Revenue range
- $1K+
- Founded
- 2009-01-01
Headquarters
- Headquarters
- Cork, Munster, Ireland
- Country code
- IE
- Continent
- Europe